BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33467760)

  • 1. Synthesis and Biological Evaluation of
    Figueiredo D; Fernandes C; Silva F; Palma E; Raposinho P; Belchior A; Vaz P; Paulo A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus.
    Fernandes C; Palma E; Silva F; Belchior A; Pinto CIG; Guerreiro JF; Botelho HM; Mendes F; Raposinho P; Paulo A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear targeting with cell-specific multifunctional tricarbonyl M(I) (M is Re, (99m)Tc) complexes: synthesis, characterization, and cell studies.
    Esteves T; Marques F; Paulo A; Rino J; Nanda P; Smith CJ; Santos I
    J Biol Inorg Chem; 2011 Dec; 16(8):1141-53. PubMed ID: 21706254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of
    Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells: kinetics, dosimetry and effect on cellular proliferation.
    Santos-Cuevas CL; Ferro-Flores G; Rojas-Calderón EL; García-Becerra R; Ordaz-Rosado D; Arteaga de Murphy C; Pedraza-López M
    Nucl Med Commun; 2011 Apr; 32(4):303-13. PubMed ID: 21304415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Preclinical Evaluation of PSMA-Targeted
    Santos JF; Braz MT; Raposinho P; Cleeren F; Cassells I; Leekens S; Cawthorne C; Mendes F; Fernandes C; Paulo A
    Mol Pharm; 2024 Jan; 21(1):216-233. PubMed ID: 37992229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.
    Yu Z; Carlucci G; Ananias HJ; Dierckx RA; Liu S; Helfrich W; Wang F; de Jong IJ; Elsinga PH
    Amino Acids; 2013 Feb; 44(2):543-53. PubMed ID: 22833158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
    Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
    Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological and dosimetric assessment of DNA-intercalated
    Belchior A; Di Maria S; Fernandes C; Vaz P; Paulo A; Raposinho P
    EJNMMI Res; 2020 Jul; 10(1):79. PubMed ID: 32661612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
    Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Preclinical Evaluation of
    Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
    Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.
    Ananias HJ; Yu Z; Hoving HD; Rosati S; Dierckx RA; Wang F; Yan Y; Chen X; Pruim J; Lub-de Hooge MN; Helfrich W; Elsinga PH; de Jong IJ
    Nucl Med Biol; 2013 Oct; 40(7):933-8. PubMed ID: 23891351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
    J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.